We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
-4.3%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$5.81B
AUM Growth
+$135M
Cap. Flow
+$468M
Cap. Flow %
8.05%
Top 10 Hldgs %
22.38%
Holding
604
New
28
Increased
196
Reduced
108
Closed
52

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$52.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$45.1M
3
PCAR icon
PACCAR
PCAR
+$42.3M
4
KLAC icon
KLA
KLAC
+$37.4M
5
AMZN icon
Amazon
AMZN
+$23.1M

Top Sells

Rank Stock Value
1
MAR icon
Marriott International
MAR
+$51.7M
2
ABT icon
Abbott
ABT
+$30.9M
3
PFE icon
Pfizer
PFE
+$29.6M
4
VSAT icon
Viasat
VSAT
+$18M
5
QCOM icon
Qualcomm
QCOM
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 31.85%
2 Healthcare 18.76%
3 Financials 9.65%
4 Consumer Discretionary 9.57%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APH icon
301
Amphenol
APH
$214B
$1.52M 0.03%
36,280
-9,800
-21% -$422K
SLF icon
302
Sun Life Financial
SLF
$45.3B
$1.49M 0.03%
30,500
QCOM icon
303
Qualcomm
QCOM
$166B
$1.47M 0.03%
13,334
-127,484
-91% -$14.8M
PCVX icon
304
Vaxcyte
PCVX
$7.98B
$1.46M 0.03%
29,000
CARR icon
305
Carrier Global
CARR
$54B
$1.44M 0.02%
25,700
PDD icon
306
Pinduoduo
PDD
$129B
$1.43M 0.02%
+15,000
New +$1.29M
LRN icon
307
Stride
LRN
$3.52B
$1.41M 0.02%
31,100
GPN icon
308
Global Payments
GPN
$24.3B
$1.41M 0.02%
12,125
+201
+2% +$23.9K
ZTS icon
309
Zoetis
ZTS
$31.1B
$1.39M 0.02%
8,014
+1,246
+18% +$226K
FOLD
310
DELISTED
Amicus Therapeutics
FOLD
$1.39M 0.02%
116,850
SRE icon
311
Sempra
SRE
$55.3B
$1.38M 0.02%
20,366
+298
+1% +$21.5K
SPG icon
312
Simon Property Group
SPG
$73B
$1.37M 0.02%
12,600
-500
-4% -$58.6K
GS icon
313
Goldman Sachs
GS
$316B
$1.35M 0.02%
4,149
+66
+2% +$22.1K
CC icon
314
Chemours
CC
$2.23B
$1.3M 0.02%
46,666
+681
+1% +$23.4K
BBD icon
315
Banco Bradesco
BBD
$38.1B
$1.3M 0.02%
458,253
BPMC
316
DELISTED
Blueprint Medicines
BPMC
$1.28M 0.02%
25,100
MFC icon
317
Manulife Financial
MFC
$73.9B
$1.27M 0.02%
68,900
PSX icon
318
Phillips 66
PSX
$81.2B
$1.27M 0.02%
+10,300
New +$1.16M
DXCM icon
319
DexCom
DXCM
$31.1B
$1.27M 0.02%
13,308
+3,200
+32% +$361K
LNG icon
320
Cheniere Energy
LNG
$53.8B
$1.27M 0.02%
7,495
-14,223
-65% -$2.29M
ITCI
321
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.26M 0.02%
23,400
XENE icon
322
Xenon Pharmaceuticals
XENE
$6.21B
$1.24M 0.02%
35,000
INSM icon
323
Insmed
INSM
$21.7B
$1.23M 0.02%
47,600
MTZ icon
324
MasTec
MTZ
$21.7B
$1.21M 0.02%
16,589
+233
+1% +$23.2K
CCI icon
325
Crown Castle
CCI
$31.9B
$1.2M 0.02%
13,076
-700
-5% -$72.5K

Similar funds

Erste Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Erste Asset Management held 604 positions worth $5.81B, up 2.4% from $5.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Erste Asset Management deployed $468M of net new capital in Q3 2023, opening 28 new positions and adding to 196 existing holdings. Its largest new stake was Constellation Brands: 50,120 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Marriott International, an estimated $51.7M trimmed.

  • Erste Asset Management's largest Q3 2023 buy was Constellation Brands: 50,120 shares worth $12.6M.
  • Erste Asset Management added most to Visa in Q3 2023, an estimated $52.7M increase.
  • Erste Asset Management's biggest Q3 2023 reduction was Marriott International, cutting an estimated $51.7M.
  • Erste Asset Management fully exited Viasat in Q3 2023, selling an estimated $18M.
  • Erste Asset Management's ten largest holdings make up 22% of its $5.81B portfolio in Q3 2023.
  • Erste Asset Management opened 28 new positions and closed 52 in Q3 2023.
  • Erste Asset Management's portfolio value rose 2.4% quarter-over-quarter to $5.81B.

Based on Erste Asset Management's 13F filing for Q3 2023, filed 26 Nov 2024.